ArticleWorld journal of urology2026
Long-term course and predictors of postpartum urinary incontinence: a three-year cohort in Portuguese women.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Machine learning-based prediction model for postpartum stress urinary incontinence risk: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- Metabolic Vulnerability and Regenerative Failure of the External Urethral Sphincter: A Ferroptosis-Associated Framework for Stress Urinary Incontinence.Biomolecules · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeUrinary incontinence (UI) is a frequent yet often underrecognized morbidity among postpartum women. Understanding its prevalence, trajectory, and risk factors is essential for informing preventive and management strategies. This study aimed to investigate the prevalence and progression of UI across four postpartum periods-first week (M1), first month (M2), first year (M3), and third year (M4)-and to identify predictors associated with UI persistence at three years postpartum.
methodsA prospective longitudinal cohort study was conducted including 139 women who completed the validated Portuguese version of the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Data were collected at M1, M4, and at least one intermediate time point (M2 or M3). Descriptive statistics and logistic regression analyses were performed to assess prevalence patterns, symptom severity, and predictors of long-term UI.
resultsUI prevalence was highest at M1 (51.1%), declined at M2 (23.0%), increased again at M3 (41.2%), and stabilized at M4 (38.1%). Stress urinary incontinence was the predominant subtype across all time points. Symptom severity tended to progress from mild-moderate (M1-M2) to moderate-severe (M3-M4) among women with persistent symptoms. Higher body mass index (BMI) and gestational duration ≥ 39 weeks were independently associated with long-term UI, increasing the odds by approximately 13% per BMI unit and 3.7-fold, respectively.
conclusionsPersistent urinary incontinence remains relatively common up to three years postpartum, particularly among women with higher body mass index and longer gestational duration. Early postpartum screening may help identify women at increased risk of persistent symptoms, although the impact of specific therapeutic interventions was not assessed in this study. Promoting pelvic floor health awareness together with weight-management counselling within routine postpartum care may inform preventive strategies for postpartum continence care, although further interventional studies are required to confirm effectiveness.
Indexed as
Identifiers
42334479What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.